Patents Assigned to Immunotec, Inc.
  • Patent number: 11944649
    Abstract: Provided herein are compositions, uses thereof, and methods for treating Autism or Autism Spectrum Disorder (ASD) in a subject in need thereof, wherein the compositions comprise a whey protein isolate and/or whey protein concentrate.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: April 2, 2024
    Assignee: IMMUNOTEC INC.
    Inventor: Ana Maria Castejon Semidey
  • Publication number: 20230029577
    Abstract: Methods for increasing reelin (RELN) levels in the brain of a subject in need thereof, as well as compositions for use in such methods, are provided. In addition, methods and compositions are described herein which may be used in the treatment of neuropsychiatric or neurodegenerative disorders, such as schizophrenia and Alzheimer's disease (AD). Compositions described herein may comprise whey protein isolate and/or whey protein concentrate, a source of the glutathione precursor cysteine. The provided methods and compositions are not limited to increasing RELN levels, and may be used to correct a number of other neurological disregulations or abnormalities occurring in a subject in need thereof.
    Type: Application
    Filed: June 9, 2022
    Publication date: February 2, 2023
    Applicant: Immunotec Inc.
    Inventors: Hyman Morris SCHIPPER, Marisa Emily CRESSATTI, Wei SONG, Carmela GALINDEZ, Ayda TAVITIAN, Adrienne LIBERMAN, Daniel A. LINSEMAN
  • Publication number: 20210379145
    Abstract: Provided herein are methods, compositions, and uses thereof for preventing traumatic brain injury (TBI) in a subject, wherein a composition comprising whey protein isolate and/or whey protein concentrate may be administered to a subject pre-injury, thereby increasing resilience of the subject to TBI.
    Type: Application
    Filed: August 16, 2021
    Publication date: December 9, 2021
    Applicant: Immunotec Inc.
    Inventors: Elizabeth E. IGNOWSKI, Daniel A. LINSEMAN
  • Publication number: 20200206270
    Abstract: Provided herein are compositions, uses thereof, and methods for treating Autism or Autism Spectrum Disorder (ASD) in a subject in need thereof, wherein the compositions comprise a whey protein isolate and/or whey protein concentrate.
    Type: Application
    Filed: July 31, 2018
    Publication date: July 2, 2020
    Applicant: Immunotec Inc.
    Inventor: Ana Maria CASTEJON SEMIDEY
  • Publication number: 20200206307
    Abstract: Provided herein are methods, compositions, and uses thereof for preventing traumatic brain injury (TBI) in a subject, wherein a composition comprising whey protein isolate and/or whey protein concentrate may be administered to a subject pre-injury, thereby increasing resilience of the subject to TBI.
    Type: Application
    Filed: June 14, 2018
    Publication date: July 2, 2020
    Applicant: Immunotec Inc.
    Inventors: Elizabeth E. IGNOWSKI, Daniel A. LINSEMAN
  • Publication number: 20190262401
    Abstract: Methods for increasing reelin (RELN) levels in the brain of a subject in need thereof, as well as compositions for use in such methods, are provided. In addition, methods and compositions are described herein which may be used in the treatment of neuropsychiatric or neurodegenerative disorders, such as schizophrenia and Alzheimer's disease (AD). Compositions described herein may comprise whey protein isolate and/or whey protein concentrate, a source of the glutathione precursor cysteine. The provided methods and compositions are not limited to increasing RELN levels, and may be used to correct a number of other neurological disregulations or abnormalities occurring in a subject in need thereof.
    Type: Application
    Filed: September 19, 2017
    Publication date: August 29, 2019
    Applicant: Immunotec Inc.
    Inventors: Hyman Morris SCHIPPER, Marisa Emily CRESSATTI, Wei SONG, Carmela GALINDEZ, Ayda TAVITIAN, Adrienne LIBERMAN, Daniel A. LINSEMAN
  • Patent number: 4822611
    Abstract: A method of treating allergies whereby hyposensitization to allergens to which the patient has been found to be sensitive by skin testing and history is induced by sequentially scheduled oral administration of titrated amounts of allergenic extracts in a liquid vehicle comprising defined proportions of a selected hexose monosaccharide and ethyl alcohol in water.
    Type: Grant
    Filed: December 9, 1986
    Date of Patent: April 18, 1989
    Assignee: Immunotec, Inc.
    Inventor: Jack C. Booren